Downregulation of huntingtin-associated protein 1 predicts poor prognosis in gastric cancer

Table 2 Relationship between huntingtin-associated protein 1 expressions and clinicopathologic features in patients with gastric cancer

Features	Low	High	P value	χ2
Cases	85	39
Age
< 55 years	30	15	0.733	0.116
≥ 55 years	55	24
Sex
Male	36	20	0.354	0.861
Female	49	19
Tumor size
< 3 cm	37	16	0.599	0.276
≥ 3 cm	48	23
Differentiation
Low	40	10	0.014	8.506
Moderate	28	12
High	17	17
Serosal invasion
No	33	21	0.117	2.454
Yes	52	18
Lymphatic metastasis
No	27	21	0.019	5.494
Yes	58	18
LNR
< 27	33	25	0.009	6.862
≥ 27	52	14
Remote metastasis
No	60	35	0.035	4.458
Yes	25	4
Clinical stage
Early	18	16	0.021	5.293
Advanced	67	23
Tumor location
Proximal	58	19	0.038	4.327
Distal	27	20

LNR: Lymph node ratio. Positive lymph node/total examined lymph nodes × 100%. Tumor size was measured based on the length of the largest tumor nodule.